Navigation Links
Cell Press journals continue to deliver high impact
Date:6/29/2012

Latest annual citation reports confirm Cell Press delivers highly valued, highly cited research and reviews to the scientific community it serves

We are delighted to report that the new impact factors align with community perception and confirm that Cell Press continues to publish the highest impact research and reviews in the biomedical sciences, according to the latest Journal Citation Reports published by Thomas Reuters.

Cell Press's flagship journal Cell received an impressive impact factor of 32.403. Showing strong and steady growth, Cell's impact factor has increased by 9% since 2005, maintaining its status as the premier research journal in its field. Cell is currently ranked the number one research journal in the 'Cell Biology' and 'Biochemistry & Molecular Biology' categories.

Over 70% of journals within the Trends review journal series increased in impact factor this year, with significant growth across several life science disciplines. Top performers include Trends in Cognitive Science, which increased by 30% to 12.586, Trends in Immunology, which grew 9% to 10.403, and Trends in Ecology and Evolution, which rose 9% to 15.748. Published by Cell Press since 2007, Trends journals offer the unparalleled level of in-house editorial expertise that exists within all of the Cell Press journals, with the support of committed and enthusiastic editorial boards and an extensive range of fair and knowledgeable reviewers.

The substantial increase for Trends in Cognitive Sciences is also reflected in the other Cell Press neuroscience journals. Neuron, which has been publishing leading neuroscience research and reviews since 1988, increased by 5% to 14.736, and Trends in Neurosciences is up from 13.320 to 14.235.

"We are very pleased to see the scientific community's response to the work published in Cell Press journals. We are grateful to the authors who entrust their best work to us and to the reviewers who provide invaluable advice and guidance," said Emilie Marcus, Editor-in-Chief and CEO of Cell Press. "Cell Press editors work hard to maintain the high editorial standards expected of them by our authors and readers, and understand the importance of engaging with, and being accessible to, the life science research community which we are all proud to be a part of."

Cell Press's more recent journal launches, aimed at expanding our scope into translational biomedical areas, continue to maintain their influence within the scientific community. Launched in 2007, Cell Stem Cell has an impact factor of 25.421 and has been named a "Rising Star (http://sciencewatch.com/inter/jou/2011/11julCellStemCell/)" in the field of Clinical Medicine by Thomson Reuters. This means that, in 2011, Cell Stem Cell had the highest percentage growth in citations in its field. Celebrating a decade of high impact publication in 2012, Cancer Cell has a well established impact factor of 26.566.

The 2011 Journal Citation Reports ranks the Cell Press journals' impact factors as follows:

Cancer Cell 26.566
Cell 32.403
Cell Host & Microbe 13.500
Cell Metabolism 13.668
Cell Stem Cell 25.421
Chemistry & Biology 5.829
Current Biology 9.647
Developmental Cell 14.030
Immunity 21.637
Molecular Cell 14.178
Neuron 14.736
Structure 6.347
AJHG 10.603
Biophysical Journal 3.653
Trends in Biochemical Sciences 10.847
Trends in Biotechnology 9.148
Trends in Cell Biology 12.354
Trends in Cognitive Sciences 12.586
Trends in Ecology & Evolution 15.748
Trends in Endocrinology & Metabolism 8.115
Trends in Genetics 10.064
Trends in Immunology 10.403
Trends in Microbiology 7.910
Trends in Molecular Medicine 10.355
Trends in Neurosciences 14.235
Trends in Parasitology 5.144
Trends in Pharmacological Sciences 10.927
Trends in Plant Science 11.047

Impact factors measure the frequency which the average article in a journal has been cited in a given year. This data helps indicate a journal's relative importance when compared to other publications in the same field.

To read more about the 2011 impact factors from Cell Press, go to www.cell.com/cellpress/impact


'/>"/>

Contact: Elisabeth (Lisa) Lyons
elyons@cell.com
617-386-2121
Cell Press
Source:Eurekalert

Related biology news :

1. Royal Astronomical Society and Oxford University Press partnership announced
2. Probing the roots of depression by tracking serotonin regulation at a new level
3. South African daffodils may be a future cure for depression
4. Selenium suppresses staph on implant material
5. Fish show autism-like gene expression in water with psychoactive pharmaceuticals
6. Common genetic mutation increases sodium retention, blood pressure
7. Press accreditation opens for World Series of Science
8. Springer and the Beijing Normal University Press sign agreement on new book series
9. Clusters of cooperating tumor-suppressor genes are found in large regions deleted in common cancers
10. Measuring progesterone receptor expression to improve hormone-receptor-positive cancer management
11. Evidence shows that anti-depressants likely do more harm than good, researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Access System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 15.1% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, announces a presentation ... San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will ...
Breaking Biology Technology: